I’m Certified in Transcranial Magnetic Stimulation. Let Me Tell You About It.

Deep TMS is a cutting-edge, FDA-cleared, non-invasive technology that treats MDD and OCD.

I’m a certified BrainsWay Deep Transcranial Magnetic Stimulation (TMS) Operator. That means I know how to operate the device shown below:

When you're a Strategic Advisor to a company or startup, it’s important to know the organization’s solution intimately in order to bring the most value. As an advisor to Minneapolis-based Psy-Fi TMS, a unique behavioral mental health clinic using the latest scientific advances to treat patients, it is important that I have first-hand knowledge of the device at hand.

Developed by Israeli-based BrainsWay, Deep TMS is a cutting-edge, FDA-cleared, non-invasive technology that uses electromagnetic waves to target the brain’s Limbic System in order to treat MDD and OCD. Research has already validated that the Limbic System is strongly interlinked with symptoms of depression. Scientists at BrainsWay leveraged this information to create novel treatment methods capable of mending the most severe cases of MDD and OCD.

According to BrainsWay, in the context of MDD “Deep TMS works by utilizing a magnetic field that manages to directly reach wider and deeper brain regions, regulating the neural activity of brain structures related to depression – specifically the dorsolateral prefrontal cortex (DLPFC). Repeated peer-reviewed studies have found Deep TMS to be a highly effective treatment that can facilitate a profound improvement in patients’ mental health, alleviating symptoms of depression and contributing to a significantly greater quality of life.”

Moreover, when it comes to OCD, “The treatment utilizes a magnetic field emitted by BrainsWay’s patented H7-coil to directly reach broader and deeper brain regions than its predecessors, regulating the neural activity of brain structures associated with OCD – specifically the anterior cingulate cortex and medial prefrontal cortex. A peer-reviewed multicenter clinical study found Deep TMS to be a highly effective OCD treatment, with more than one in three treatment-resistant OCD patients achieving “response”, greatly improving their quality of life.”

BrainsWay also offers a variety of other cutting-edge Psychiatric and Neurological treatments for medical conditions like Bipolar Disorder, PTSD, Schizophrenia, Alzheimer’s, Autism, Chronic Pain, MS, Parkinson's Disease, and Post Stroke Rehabilitation (although these treatments are not available for commercial use in the US yet).

I add value to the clinic by providing guidance on how to better attract a younger patient demographic, namely Gen Z ages 18-24. For as highly connected as our Digital Native generation may appear, few kids my age are aware of alternative treatments for MDD and OCD. This is an enormous problem. Depression rates have soared among adolescents recently, accelerated by the Pandemic-induced stress. According to a recent paper by the University of Surrey, “Levels of clinical depression in those surveyed [youth] were found to have more than doubled, rising from 14.9 per cent in autumn 2019 to 34.7 per cent in May/June 2020.” Another report by the APA showed that “More than seven in 10 Gen-Z adults surveyed said they experienced common symptoms of depression in the prior two weeks.”

Covid was also shown to exacerbate OCD in youth, “Children and adolescents with obsessive-compulsive disorder have experienced worsened symptoms amid the COVID-19 pandemic, according to a study published in BMC Psychiatry. Results showed 44.6% of patients in the clinical group and 73% of patients in the survey group reported a worsening of symptoms.”

With this knowledge in mind, Gen Z-ers seem to resemble more of Generation “Gloom and Doom” rather than the up-beat Digital Natives they are commonly known to be. However, as the MedTech scene matures (especially in Minnesota, which can be considered the MedTech capital of the U.S), I have confidence that knowledge of such treatments as Deep TMS will become more widespread and recognized throughout the healthcare community.

14 views0 comments